EU
Investment Plan supports development of therapies for rare genetic diseases
The European Investment Bank (EIB), backed by the European Fund for Strategic Investments (EFSI), will provide €25 million of financing to Minoryx Therapeutics. Minoryx is a biotech company specializing in the advancement of treatments for rare central nervous system disorders. The newly available funding will thus benefit Minoryx's research and development activities in orphan genetic diseases for which there are currently no approved drugs available.
Economy Commissioner Paolo Gentiloni, said: “This EU support will help Minoryx to develop breakthrough therapies for genetic diseases and treatments for diseases of the central nervous system. The coronavirus pandemic has shown how important it is to continue to push scientific boundaries and deliver medication for rare diseases. The European Commission will continue to support companies' efforts in this sense at every opportunity.”
The press release is available here. So far, the Investment Plan for Europe has mobilized €535 billion of investment across the EU, a quarter of which is supporting research, development and innovation projects.
Share this article:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Counterfeit cigarettes drive illicit tobacco trade to highest level in a decade, new study claims
Libya’s fuel crisis offers lessons for energy security on both sides of the Mediterranean
Spring semester package: Steering EU economies to increased competitiveness
In space, we can’t defend what we can’t see
EU Cybersecurity Act could expose member states to costly investment treaty claims, legal opinion warns
OceanEye: Placing the EU at the forefront of ocean observation
Kazakhstan seeks deeper EU partnership in science, education and innovation
Outrage of Iranian exiles and opposition of MEPs to inviting Reza Pahlavi to the European Parliament
EDF’s first-ever FSTP sub-call attracts strong interest from newcomers to EU defence funding
EU implements Palestine facility with $395 million for local banks and €2.1 million in technical assistance
EU exports of shark fins dropped in 2025
Commission approves €23 billion Italian state aid scheme to support renewable electricity production
Justice and Home Affairs Council
Give your career a real take off
Serbia’s business environment is driving its integration into the EU
The Hidden Cost of Aid Cuts.
Kazakhstan reforms under scrutiny at Brussels Press Club round table
Japan should face up to history and contribute more to regional peace
Ambassador calls for 'speeding up' of co-operation between EU and Kazakhstan
Timur Turlov at Smart Moves Summit 2025: How chess can transform global education
Shevtsova’s case: Out-of-court sanctions dismantling trust in Ukrainian cause
The future of European transport
Trump Vs Trueman
US 'no longer' an 'unconditional ally' for Europe - MEP
-
Health4 days agoCounterfeit cigarettes drive illicit tobacco trade to highest level in a decade, new study claims
-
Libya4 days agoLibya’s fuel crisis offers lessons for energy security on both sides of the Mediterranean
-
European Commission4 days agoSpring semester package: Steering EU economies to increased competitiveness
-
Space4 days agoIn space, we can’t defend what we can’t see